Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 116 of 116 entries
View as:

High-activity Natural Killer Immunotherapy for Small Metastases of Tongue Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03008330 Org: User:
Start: 12/01/16 End: 06/01/19 Due: 06/01/20

Safety and Effectivity Immunotherapy to Treat Ovarian Cancer With Cancer Stem Cells Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02178670 Org: User:
Start: 06/30/14 End: 04/30/15 Due: 04/30/16

Nano Drug Interventional Therapy Using Digital Subtraction Angiography（DSA） for Liver Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02449109 Org: User:
Start: 05/31/15 End: 02/29/16 Due: 02/28/17

Irreversible Electroporation(IRE) For Unresectable Lymph Node Metastases(Close to Nerve)

Phase: N/A Priority: Normal
NCT ID: NCT02430766 Org: User:
Start: 01/01/15 End: 02/01/21 Due: 02/01/22

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA） for Nasopharyngeal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02523430 Org: User:
Start: 05/31/15 End: 06/30/16 Due: 06/30/17

Irreversible Electroporation(IRE) For Unresectable Renal Pelvic and Ureteral Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT02430779 Org: User:
Start: 01/01/15 End: 01/01/21 Due: 01/01/22

Combination of Cryosurgey and NK Immunotherapy for Recurrent Pharyngeal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02849327 Org: User:
Start: 07/01/16 End: 07/01/19 Due: 07/01/20

Combination of PD-1 and VEGFR-2 Blockade for Advanced Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04393220 Org: User:
Start: 05/11/20 End: 08/31/21 Due: 08/31/22

Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT02430623 Org: User:
Start: 01/01/15 End: 03/01/21 Due: 03/01/22

Irreversible Electroporation(IRE) For Unresectable Rectal Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT02425059 Org: User:
Start: 01/01/15 End: 02/01/21 Due: 02/01/22

The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02450448 Org: User:
Start: 06/30/13 End: 12/31/15 Due: 12/31/16

Cancer Stem Cells Vaccine Therapy in Treating Hepatocellular Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02089919 Org: User:
Start: 02/28/14 End: 02/28/15 Due: 02/28/16

Safety and Efficiency of IRE Plus γδ T Cell Against Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03180437 Org: User:
Start: 06/15/17 End: 06/15/19 Due: 06/15/20

PENS or TENS for Pain in Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03331055 Org: User:
Start: 10/27/17 End: 08/26/19 Due: 08/26/20

CD19-targeting CAR T Cells for B Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02547948 Org: User:
Start: 09/30/15 End: 08/15/16 Due: 08/15/17

Safety and Efficiency of γδ T Cell Against Breast Cancer(Her-, er-, and pr-)

Phase: N/A Priority: Normal
NCT ID: NCT02418481 Org: User:
Start: 04/30/15 End: 06/30/16 Due: 06/30/17